{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:20:09Z","timestamp":1771190409204,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Pharm Res"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/bf02972986","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T08:12:17Z","timestamp":1241683937000},"page":"1196-1202","source":"Crossref","is-referenced-by-count":12,"title":["Effect of cimetidine and phenobarbital on metabolite kinetics of omeprazole in rats"],"prefix":"10.1007","volume":"28","author":[{"given":"Eun-Ja","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hea-Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02972986_CR1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2125.1994.tb04310.x","volume":"37","author":"T. Andersson","year":"1994","unstructured":"Andersson, T., Miners, J. O., Veronese, M. E., and Birkett, D. J., Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.Br. J. Clin. Pharmacol., 37, 597\u2013604 (1994).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF02972986_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2125.1993.tb00410.x","volume":"36","author":"T. Andersson","year":"1993","unstructured":"Andersson, T., Miners, J. O., Veronese, M. E., Tassaneeyakul, W., Meyer, U. A., and Birkett, D. J., Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.Br. J. Clin. Pharmacol., 36, 521\u2013530 (1993).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF02972986_CR3","first-page":"248","volume":"33","author":"D. K. Badyal","year":"2001","unstructured":"Badyal, D. K. and Dadhich, A. P., Cytochrome p450 and drug interactions.Indian J. Pharmacol., 33, 248\u2013259 (2001).","journal-title":"Indian J. Pharmacol."},{"key":"BF02972986_CR4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF01469004","volume":"54","author":"J. W. Black","year":"1976","unstructured":"Black, J. W., Histamine H2-receptor antagonists and gastric acid secretion-A progress report.Klin. Wochenschr., 54, 911\u2013914 (1976).","journal-title":"Klin. Wochenschr."},{"key":"BF02972986_CR5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1172\/JCI107647","volume":"53","author":"R. A. Branch","year":"1974","unstructured":"Branch, R. A., Shand, D. G., Wilkinson, G. R., and Nies, A. S., Increased clearance of antipyrine andd-propranolol after phenobarbital treatment in the monkey; Relative contributions of enzyme induction and increased hepatic blood flow.J. Clin. Invest., 53, 1101 (1974).","journal-title":"J. Clin. Invest."},{"key":"BF02972986_CR6","first-page":"903","volume":"25","author":"D. J. Carlile","year":"1997","unstructured":"Carlile, D. J., Zomorodi, K., and Houston, J. B., Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver studies with induced livers involving diazepam.Drug Metab. Dispos., 25, 903\u2013911 (1997).","journal-title":"Drug Metab. Dispos."},{"key":"BF02972986_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0021-9673(01)01225-0","volume":"949","author":"F. C. Cheng","year":"2002","unstructured":"Cheng, F. C., Ho, Y. F., Hung, L. C., Chen, C. F., and Tsai, T. H., Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography.J. Chromatogr. A, 949, 35\u201342 (2002).","journal-title":"J. Chromatogr. A"},{"key":"BF02972986_CR8","volume-title":"Pharmacokinetic and pharmacodynamic data analysis: concepts & applications","author":"J. Gabrielsson","year":"2000","unstructured":"Gabrielsson, J. and Weiner, D., Pharmacokinetic and pharmacodynamic data analysis: concepts & applications 3rd edition, Apotekarsocieteten, Stockholm, (2000).","edition":"3rd edition"},{"key":"BF02972986_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2165\/00003088-199120010-00003","volume":"20","author":"C. W. Howden","year":"1991","unstructured":"Howden, C. W., Clinical pharmacology of omeprazole.Clin. Pharmacokinet., 20, 38\u201349 (1991).","journal-title":"Clin. Pharmacokinet."},{"key":"BF02972986_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-4165(02)00482-8","volume":"1619","author":"S. Kakizaki","year":"2003","unstructured":"Kakizaki, S., Yamamoto, Y., Ueda, K., Moore, R., Sueyoshi, T., and Negishi, M., Phenobarbital induction of drug\/steroid-metabolizing enzymes and nuclear receptor CAR.Biochim. Biophys. Acta, 1619, 239\u2013242 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"BF02972986_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0016-5085(82)90127-5","volume":"82","author":"R. G. Knodell","year":"1982","unstructured":"Knodell, R. G., Holtzmann, D. L., Crankshaw, D. L., Steele, N. M., and Stanley, L. N., Drug metabolism by rat and human microsomes in response to interaction with H2-receptor.Gastroenterology, 82, 84\u201388 (1982).","journal-title":"Gastroenterology"},{"key":"BF02972986_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0378-4347(92)80395-7","volume":"579","author":"K. Kobayashi","year":"1992","unstructured":"Kobayashi, K., Chiba, K., Sohn, D. R., Kato, Y., and Ishizaki, T., Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymercoated C18 column.J. Chromatogr., 579, 299\u2013305 (1992).","journal-title":"J. Chromatogr."},{"key":"BF02972986_CR13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1389200033489325","volume":"4","author":"R. H. Levy","year":"2003","unstructured":"Levy, R. H., Hachad, H., Yao, C., and Ragueneau-Majlessi, I., Relationship between extent of inhibition and inhibitor dose, literature evaluation based on the metabolism and transport drug interaction database.Curr. Drug Metab., 4, 371\u2013380 (2003).","journal-title":"Curr. Drug Metab."},{"key":"BF02972986_CR14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1432-1327.2000.01083.x","volume":"267","author":"N. Marc","year":"2000","unstructured":"Marc, N., Galisteo, M., Lagadic-Gossmann, D., Fautrel, A., Joannard, F., Guillouzo, A., and Corcos, L., Regulation of phenobarbital induction of the cytochrome P450 2b9\/10 genes in primary mouse hepatocyte culture.Eur. J. Biochem., 267, 963\u2013970 (2000).","journal-title":"Eur. J. Biochem."},{"key":"BF02972986_CR15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1177\/002215549804601007","volume":"46","author":"K. Mino","year":"1998","unstructured":"Mino, K., Watanabe, J., and Kanamura, S., Effect of 3-methyl-cholanthrene administration on expression of cytochrome P-450 isoforms induced by phenobarbital in rat hepatocytes.J. Histochem Cytochem., 46, 1151\u20131160 (1998).","journal-title":"J. Histochem Cytochem."},{"key":"BF02972986_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.1995.tb00344.x","volume":"9","author":"K. U. Petersen","year":"1994","unstructured":"Petersen, K. U., Omeprazole and the cytochrome P450 system.Aliment. Pharmacol. Ther., 9, 1\u20139 (1994).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BF02972986_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00365528509095821","volume":"108","author":"C. G. Regardh","year":"1985","unstructured":"Regardh, C. G., Gabrielsson, M., Hoffman, K. J., Lofberg, I., and Skanberg, I., Pharmacokinetics and metabolism of omeprazole in animals and man.Scan. J. Gastroenterol. Suppl., 108, 79\u201394 (1985).","journal-title":"Scan. J. Gastroenterol. Suppl."},{"key":"BF02972986_CR18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1067\/mcp.2000.104018","volume":"67","author":"T. Shiga","year":"2000","unstructured":"Shiga, T., Hashiguchi, M., Urae, A., Kasanuki, H., and Rikihisa, T., Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.Clin. Pharmacol. Ther., 67, 222\u2013228 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02972986_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-2275(20)41206-4","volume":"35","author":"E. Sudjana-Sugiaman","year":"1994","unstructured":"Sudjana-Sugiaman, E., Eggertsen, G., and Bjorkhem, I., Stimulation of HMG-CoA reductase as a consequence of phenobarbital-induced primary stimulation of cholesterol 7 alpha-hydroxylase in rat liver.J. Lipid Res., 35, 319\u2013327 (1994).","journal-title":"J. Lipid Res."},{"key":"BF02972986_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.18388\/abp.2002_3842","volume":"49","author":"M. M. Szutowski","year":"2002","unstructured":"Szutowski, M. M., Zalewska, K., Jadczak, M., and Marek, M.,In vivo effect of diallyl sulfide and cimetidine on phenacetin metabolism and bioavailability in rat.Acta Biochim. Pol., 49, 249\u2013256 (2002).","journal-title":"Acta Biochim. Pol."},{"key":"BF02972986_CR21","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.1016\/S0021-9258(18)34039-0","volume":"257","author":"D. J. Waxman","year":"1982","unstructured":"Waxman, D. J. and Walsh, C., Phenobarbital-induced rat liver cytochrome P-450. Purification and characterization of two closely related isozymic forms.J. Bio. Chem., 257, 10446\u201310454 (19820.","journal-title":"J. Bio. Chem."},{"key":"BF02972986_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003495-199448010-00008","volume":"48","author":"M. I. Wilde","year":"1994","unstructured":"Wilde, M. I. and McTavish, D., Omeprazole: An update of its pharmacology and therapeutic use in acid-related disorders.Drugs, 48, 91\u2013131 (1994).","journal-title":"Drugs"},{"key":"BF02972986_CR23","unstructured":"WinNonlinTM User's Guide Ver. 3.0, Pharsight Corp., Mountain View, CA, U.S.A. (1999)."},{"key":"BF02972986_CR24","volume-title":"Clinical Hematology","author":"M. M. Wintrobe","year":"1974","unstructured":"Wintrobe, M. M., Lee, G. R., and Boggs, D. R., Clinical Hematology 7th ed. Lea & Febiger, Philadelphia (1974).","edition":"7th ed."},{"key":"BF02972986_CR25","first-page":"443","volume":"29","author":"K. Yamano","year":"2001","unstructured":"Yamano, K., Yamamoto, K., Katashima, M., Kotaki, H., Takedomi, S., Matsuo, H., Ohtani, H., Sawada, Y., and Iga, T., Prediction of midazolam-CYP3A inhibitors interaction in the human liver fromin vivolin vitro absorption, distribution, and metabolism data.Drug Metab. Dispos., 29, 443\u2013452 (2001).","journal-title":"Drug Metab. Dispos."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02972986.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02972986\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02972986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T01:32:43Z","timestamp":1633397563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02972986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["BF02972986"],"URL":"https:\/\/doi.org\/10.1007\/bf02972986","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}